Truvy 7-Day Experience Kit Recalled for Unacceptable Dietary Ingredients
TruVision Health LLC is recalling Truvy 7-Day Experience Kit because the product contains DMHA and/or hordenine, which FDA determined are not acceptable dietary ingredients.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This recall involves a dietary supplement containing ingredients FDA has determined are not acceptable, presenting a potential health risk. The product qualifies as a risk-of-harm item where injury has not been reported, fitting FDA Class II criteria.
Plain-English summary
TruVision Health LLC is recalling 13,581 packs of Truvy 7-Day Experience Kit due to the presence of DMHA and/or hordenine. The FDA has determined these ingredients are not acceptable for use in dietary supplements.
The recalled product, identified by Lot 41404, was distributed to consumers across all 50 U.S. states as well as internationally to Australia, Canada, England, Germany, Ireland, and New Zealand. Consumers who have purchased this product should discontinue use and consult with their healthcare provider if they have any concerns.
The recalled product
- Product
- Truvy 7-Day Experience Kit
- Manufacturer
- TruVision Health LLC
- Category
- Drug — Dietary Supplement
- Hazard
- dmha
- hordenine
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 41404
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27